De Stefano, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 11.884
AS - Asia 7.726
EU - Europa 7.165
SA - Sud America 1.672
Continente sconosciuto - Info sul continente non disponibili 379
AF - Africa 217
OC - Oceania 25
Totale 29.068
Nazione #
US - Stati Uniti d'America 11.485
SG - Singapore 3.699
DE - Germania 1.685
CN - Cina 1.565
BR - Brasile 1.345
IT - Italia 1.328
SE - Svezia 1.167
VN - Vietnam 778
FR - Francia 636
UA - Ucraina 490
GB - Regno Unito 370
IE - Irlanda 370
IN - India 276
FI - Finlandia 268
ID - Indonesia 260
BD - Bangladesh 259
PL - Polonia 256
CA - Canada 187
RU - Federazione Russa 181
JP - Giappone 180
HK - Hong Kong 152
AR - Argentina 135
MX - Messico 114
IQ - Iraq 105
TR - Turchia 84
AT - Austria 73
NL - Olanda 64
ZA - Sudafrica 55
ES - Italia 52
PK - Pakistan 51
SA - Arabia Saudita 42
BE - Belgio 41
EC - Ecuador 41
KR - Corea 40
CO - Colombia 39
VE - Venezuela 33
CI - Costa d'Avorio 29
CZ - Repubblica Ceca 24
MA - Marocco 24
UZ - Uzbekistan 24
IR - Iran 23
CL - Cile 22
JM - Giamaica 21
AE - Emirati Arabi Uniti 20
AU - Australia 20
LT - Lituania 20
PY - Paraguay 20
DZ - Algeria 18
KE - Kenya 18
PH - Filippine 18
PE - Perù 17
RO - Romania 17
AZ - Azerbaigian 16
CH - Svizzera 16
JO - Giordania 16
TN - Tunisia 16
CR - Costa Rica 15
EG - Egitto 14
HU - Ungheria 14
OM - Oman 14
NP - Nepal 13
PT - Portogallo 13
IL - Israele 12
MY - Malesia 12
UY - Uruguay 11
KZ - Kazakistan 10
TH - Thailandia 10
DO - Repubblica Dominicana 9
GT - Guatemala 9
LB - Libano 9
ET - Etiopia 8
GR - Grecia 8
MD - Moldavia 8
NO - Norvegia 8
SN - Senegal 8
AL - Albania 7
BO - Bolivia 7
HN - Honduras 7
LV - Lettonia 7
BG - Bulgaria 6
HR - Croazia 6
PR - Porto Rico 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
BB - Barbados 5
BH - Bahrain 5
DK - Danimarca 5
EE - Estonia 5
LY - Libia 5
NI - Nicaragua 5
PA - Panama 5
TW - Taiwan 5
BY - Bielorussia 4
BZ - Belize 4
KG - Kirghizistan 4
NG - Nigeria 4
RS - Serbia 4
TT - Trinidad e Tobago 4
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
Totale 28.636
Città #
Singapore 1.980
Chandler 1.156
Ashburn 1.055
San Jose 947
Dublin 361
Beijing 316
Jacksonville 280
San Mateo 275
Rome 260
Dallas 258
New York 258
Los Angeles 253
Munich 251
Ho Chi Minh City 248
Jakarta 221
Wilmington 213
Warsaw 211
Lauterbourg 205
Milan 201
Hanoi 197
Nanjing 185
Boston 168
Ann Arbor 161
Cattolica 160
Fairfield 147
Tokyo 147
Dearborn 143
Hong Kong 137
Houston 131
Hefei 130
Woodbridge 122
Chicago 115
Helsinki 107
Frankfurt am Main 105
Moscow 103
São Paulo 101
Princeton 99
Redmond 95
Marseille 94
Seattle 94
Lawrence 90
Santa Clara 83
The Dalles 83
Atlanta 79
Redwood City 76
Nanchang 68
Buffalo 67
Hyderabad 64
Boardman 60
Orem 57
Council Bluffs 56
Da Nang 50
Nuremberg 49
Nürnberg 49
Paris 48
Phoenix 46
London 45
Rio de Janeiro 45
Toronto 44
Montreal 43
Bremen 42
San Francisco 40
Brooklyn 39
Belo Horizonte 38
Brussels 37
Kent 36
Memphis 36
Norwalk 36
Hebei 35
Seoul 35
Baghdad 34
Kunming 33
Mexico City 33
Mountain View 33
Cambridge 32
Guangzhou 32
Haiphong 32
Johannesburg 32
Vienna 32
Washington 32
Detroit 30
Hangzhou 30
Shanghai 30
University Park 30
Zhengzhou 30
Abidjan 29
Florence 29
Naples 28
Shenyang 28
Tianjin 28
Lancaster 27
Jiaxing 26
Poplar 26
Pune 26
St Louis 26
Denver 25
Dhaka 25
Düsseldorf 25
Izmir 25
Leawood 25
Totale 14.139
Nome #
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 452
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 373
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 355
Clinical outcomes under hydroxyurea treatment in polycythemia vera: A systematic review and meta-analysis 342
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 331
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 320
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 317
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 305
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 299
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 294
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 288
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 253
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 246
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 246
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 245
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 243
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 237
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 233
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 232
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 232
A real-time integrated framework to support clinical decision making for covid-19 patients 207
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 204
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 204
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 202
Risk factor and etiology analysis of ischemic stroke in young adult patients 201
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 200
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 194
High Frequency of Germline ATM Variants in Familial Philadelphia-Negative Myeloproliferative Neoplasms 193
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 191
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 188
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 185
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 185
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 184
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 178
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 178
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 175
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 174
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 174
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 174
Venous thromboembolism in multiple myeloma 173
External validation of the DASH prediction rule: a retrospective cohort study 171
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 169
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 168
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 167
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 166
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 165
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 165
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 163
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 162
Postpartum hemorrhage 159
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 158
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 158
Ineherited Thrombophilia: treatment during pregnancy 157
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 155
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 153
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 152
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 151
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 150
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 149
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 149
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 149
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 148
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 146
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 145
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 144
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 144
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 143
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 142
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 142
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 142
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 141
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 140
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 139
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 137
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 136
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 134
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 134
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 133
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 132
Inherited thrombophilia: treatment during pregnancy. 132
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 132
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 130
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 130
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 128
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 127
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis 125
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 124
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 123
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 121
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 121
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: A survey by the GIMEMA Haemostasis and Thrombosis Working Party 121
THE IMPACT OF EDUCATION ON PATIENTS' PSYCHOEMOTIONAL STATUS DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE PROSPECTIVE STUDY BY THE GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO 120
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 120
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 120
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 120
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 120
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 119
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 119
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 116
Totale 18.111
Categoria #
all - tutte 123.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.534 0 103 25 76 100 29 24 256 80 108 318 415
2022/20233.335 505 471 290 478 205 374 174 224 364 91 109 50
2023/20241.721 74 500 55 75 76 232 105 95 32 59 188 230
2024/20253.952 97 134 272 118 330 111 214 213 633 387 756 687
2025/202610.458 1.512 317 754 1.114 1.803 514 1.676 485 682 671 478 452
2026/20272.746 723 2.023 0 0 0 0 0 0 0 0 0 0
Totale 29.068